Fox Run Management L.L.C. Purchases New Holdings in Privia Health Group, Inc. $PRVA

Key Points

• Fox Run Management L.L.C. has acquired a $277,000 position in Privia Health Group, purchasing 12,317 shares in the first quarter.
• Privia Health's stock has experienced a slight decline of 0.7%, with its current price at $21.21 and a market cap of $2.60 billion.
• The company's recent earnings report showed a 23.4% increase in revenue year-over-year, but it missed EPS estimates, reporting $0.02 compared to the expected $0.05.

Fox Run Management L.L.C. acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 12,317 shares of the company's stock, valued at approximately $277,000.

A number of other large investors have also made changes to their positions in PRVA. Van Berkom & Associates Inc. acquired a new stake in Privia Health Group during the first quarter worth about $45,207,000. Nuveen LLC bought a new stake in shares of Privia Health Group in the 1st quarter worth approximately $26,899,000. Durable Capital Partners LP grew its holdings in shares of Privia Health Group by 3.4% during the 4th quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company's stock worth $224,587,000 after purchasing an additional 378,255 shares in the last quarter. Royce & Associates LP acquired a new stake in shares of Privia Health Group during the 1st quarter worth approximately $6,818,000. Finally, BlackBarn Capital Partners LP increased its position in shares of Privia Health Group by 65.8% during the fourth quarter. BlackBarn Capital Partners LP now owns 663,397 shares of the company's stock valued at $12,969,000 after purchasing an additional 263,397 shares during the period. Institutional investors and hedge funds own 94.48% of the company's stock.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA traded down $0.59 during trading on Monday, reaching $21.40. The stock had a trading volume of 405,394 shares, compared to its average volume of 1,026,014. The stock has a market capitalization of $2.63 billion, a PE ratio of 194.56, a P/E/G ratio of 3.19 and a beta of 0.80. Privia Health Group, Inc. has a 52 week low of $16.47 and a 52 week high of $26.09. The business's 50-day moving average price is $20.91 and its 200 day moving average price is $22.69.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). The business had revenue of $521.15 million for the quarter, compared to analyst estimates of $466.97 million. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The company's revenue for the quarter was up 23.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.19 earnings per share. Privia Health Group has set its FY 2025 guidance at EPS. Analysts forecast that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently commented on PRVA. Piper Sandler reduced their target price on Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a research report on Monday, August 11th. JMP Securities reaffirmed a "market outperform" rating and set a $29.00 price objective on shares of Privia Health Group in a report on Monday, April 28th. JPMorgan Chase & Co. lifted their target price on shares of Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday, May 28th. Zacks Research raised shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 19th. Finally, Evercore ISI cut their price target on shares of Privia Health Group from $30.00 to $28.00 and set an "outperform" rating for the company in a research note on Wednesday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $28.00.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.